DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Cortesi PA, Castaman G, Trifirò G. , et al.
Cost-effectiveness and budget impact of emicizumab prophylaxis in haemophilia A patients with inhibitors.
Thromb Haemost 2020;
120 (02) 216-228
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.